Section 19a-269b - Screening for kidney disease. Clinical laboratories(a) As used in this section, "clinical laboratory" has the same meaning as provided in section 19a-490 .(b) Beginning September 1, 2006: (1) Any person, firm or corporation operating a clinical laboratory licensed in this state shall ensure that when the clinical laboratory tests a specimen to determine a patient's serum creatinine level, as ordered or prescribed by a physician or provider in a hospital, the clinical laboratory shall (A) calculate the patient's estimated glomerular filtration rate using the patient's age and gender, which information shall be provided to the clinical laboratory by the physician or the provider in a hospital, and (B) include the patient's estimated glomerular filtration rate with its report to the physician or the provider in a hospital.(2) A person, firm or corporation operating a clinical laboratory licensed in this state shall be deemed in compliance with subdivision (1) of this subsection if the clinical laboratory makes available to the ordering physician or provider in a hospital test order codes for serum creatinine that include eGFR.Conn. Gen. Stat. § 19a-269b
( P.A. 06-120 , S. 1 ; 06-195 , S. 53 ; P.A. 07-53 , S. 1 ; P.A. 08-184 , S. 36 .)
Amended by P.A. 22-0058, S. 27 of the Connecticut Acts of the 2022 Regular Session, eff. 10/1/2022.